The conference addressed long-term effectiveness HIV of drugs, co-infections with tuberculosis or viral hepatitis and other co-morbidities, and most inequitable access to care across Europe

​From 18 to 25 November 2016, almost 500 organisations all across Europe hosted activities to increase awareness of the benefits of HIV and hepatitis testing.